NCT06461039 - A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 14, 2024

Primary Completion Date

March 16, 2025

Study Completion Date

April 4, 2025

Conditions

Obesity

Interventions

DRUG

NNC0487-0111 A

NNC0487-0111 A will be administered subcutaneously.

DRUG

NNC0487-0111 C

NNC0487-0111 C will be taken orally.

DRUG

Levonorgestrel 150 μg + Ethinylestradiol 30 μg (Oral contraceptive OC)

Levonorgestrel 150 μg + Ethinylestradiol 30 μg (Oral contraceptive OC) will be taken orally.

DRUG

Acetaminophen - 500 mg/15 ml

Acetaminophen - 500 mg/15 ml will be taken orally.

Trial Locations (1)

Altasciences Clinical Company, Inc, Montreal